Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

P06241 (FYN_HUMAN) Homo sapiens (Human)

Tyrosine-protein kinase Fyn UniProtKBInterProSTRINGInteractive Modelling

537 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3); 22 identical sequences

Available Structures

50 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Fyn SH2 domain in complex with the natural inhibitory phosphotyrosine peptide Heteromer
149-537
Assess
NMR STRUCTURE OF THE FYN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE, 22 STRUCTURES Heteromer
P03079;
143-248
Assess
NMR STRUCTURE OF THE FYN SH2 DOMAIN COMPLEXED WITH A PHOSPHOTYROSYL PEPTIDE, MINIMIZED AVERAGE STRU… Heteromer
P03079;
143-248
Assess
Human Fyn-SH2 domain in complex with a synthetic high-affinity phospho-peptide Heteromer
P03079;
148-247
15P;NA;
Assess
Crystal Structure of the Human Fyn SH3 domain in complex with a peptide from the Hepatitis C virus … Heteromer
P26663;
81-143
GOL;CL;NA;
Assess
Crystal structure of SAP/FynSH3/SLAM ternary complex Heteromer
O60880; Q13291;
84-144
FLC;
Assess
NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE KINASE COMPLEXED WITH THE SYNTH… Heteromer
P27986;
84-141
Assess
NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE COMPLEXED WITH THE SYNTHETIC PE… Heteromer
P27986;
84-141
Assess
Tau-S214 Phosphorylation Inhibits Fyn Kinase Interaction and Increases the Decay Time of NMDAR-medi… Heteromer
P10636;
85-141
Assess
HIV-1 NEF PROTEIN IN COMPLEX WITH R96I MUTANT FYN SH3 DOMAIN Heteromer
P03406;
85-141
PBM;
Assess
Crystal structure of HIV-1 NEF Fyn-SH3 R96W variant Heteromer
P03406;
85-141
Assess
V-1 NEF PROTEIN IN COMPLEX WITH WILD TYPE FYN SH3 DOMAIN Heteromer
P03406;
85-141
Assess
Complex of the human FYN SH3 and monobody binder Heteromer
85-141
Assess
CRYSTAL STRUCTURE OF THE SH3 DOMAIN IN HUMAN FYN; COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF…homo-4-mer84-142
Assess
Crystal structure of the Fyn-SH3 domain in complex with the high affinity peptide APP12homo-4-mer84-141
Assess
Swapped dimer of the human Fyn-SH2 domainhomo-2-mer148-248
PO4;EDO;
Assess
Crystal Structure of Fyn kinase domain complexed with staurosporinemonomer261-523
STU;
Assess
CRYSTAL STRUCTURE OF FYN SH3-SH2monomer85-245
Assess
Structure of Fyn protein SH2 boundmonomer149-248
Assess
human Fyn SH2 free statemonomer149-248
Assess
Fragment of a tyrosine-protein kinasemonomer83-146
GOL; 14×UNX;
Assess
His-tagged Fyn SH3 domain R96I mutantmonomer82-144
Assess
human Fyn SH3 domain R96I mutant, crystal form Imonomer80-142
PG4;
Assess
Fyn SH3 domain R96W mutant, crystallized with 18-crown-6monomer82-143
O4B;
Assess
PHOSPHOTRANSFERASEmonomer81-142
Assess
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant in complex with VSL12 …monomer83-142
Assess
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 4.5monomer83-142
PGE;
Assess
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant in complex with VSL12 …monomer83-142
Assess
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant in complex with VSL12 …monomer83-142
CIT;
Assess
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 6.0monomer83-142
Assess
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T at pH 4.5monomer83-142
ACT;
Assess
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E129Q at pH 4.0monomer83-142
Assess
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 5.0 with PEGmonomer84-142
PGE;
Assess
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 5.0monomer83-141
Assess
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant in complex with VSL12 …monomer83-141
Assess
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 4.0monomer83-141
ACT;
Assess
Crystal structure of the Fyn SH3 domain A95S-D99T mutant in space group P21monomer84-142
FMT;NA;
Assess
human Fyn SH3 domain R96I mutant, crystal form IImonomer84-142
Assess
Crystal structure of the human Fyn SH3 R96W mutantmonomer84-142
PG5;
Assess
Inferential Structure Determination of the Fyn SH3 domain using NOESY data from a 15N,H2 enriched p…monomer84-142
Assess
Crystal structure of the Fyn SH3 domain L112V-S114N-S115T-E121L-R123H mutant at pH 3.0 with PEGmonomer84-141
PG4;SO4;
Assess
Crystal structure of the Fyn SH3 domain A95S-D99T mutant in C21 space groupmonomer85-142
NA;SO4;
Assess
Crystal structure of the Fyn SH3 domain in space group P1 at pH 7.5monomer85-142
NA;
Assess
Crystal structure of the Fyn SH3 domain in space group C21 at pH 7.5monomer85-142
NA;
Assess
Crystal Structure of the Human Fyn SH3 domain in complex with the synthetic peptide VSL12monomer84-141
NA;
Assess
NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE, FAMILY OF 20 STRUCTURESmonomer84-141
Assess
NMR STUDY OF THE SH3 DOMAIN FROM FYN PROTO-ONCOGENE TYROSINE KINASE, MINIMIZED AVERAGE (PROBMAP) ST…monomer84-141
Assess
Crystal Structure of the Human Fyn SH3 domainmonomer85-141
GOL;FMT;NA;
Assess
Crystal structure of the Fyn SH3 domain mutant E129Q in space group C21 at pH 4.0monomer85-141
FMT;NA;
Assess
Designed Enzyme SH3-588 (Catechol O-methyltransferase catalytic domain and Src homology 3 binding d…monomer86-141
SAH;K;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2h8h.1.Amonomer0.7986-533
75.85
Assess
1y57.1.Amonomer0.7984-537
77.61
Assess

6 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 22h8h.1.Amonomer0.8186-530
76.69
Assess
Isoform 21y57.1.Amonomer0.8084-534
MPZ;78.71
Assess
Isoform 32src.1.Amonomer0.7885-482
80.45
Assess
Isoform 31y57.1.Amonomer0.7784-482
80.45
Assess
Isoform 33u4w.1.Amonomer0.75201-482
79.48
Assess
Isoform 34xi2.1.Amonomer0.7084-471
37.57
Assess